Shares of Schroders plc (LON:SDR – Get Free Report) have earned a consensus recommendation of “Hold” from the seven ratings firms that are covering the company, MarketBeat.com reports. Four research analysts have rated the stock with a hold rating and three have given a buy rating to the company. The average 12 month target price among brokers that have updated their coverage on the stock in the last year is GBX 409.57.
Several analysts have recently weighed in on SDR shares. UBS Group reissued a “buy” rating and issued a GBX 455 target price on shares of Schroders in a report on Friday, October 17th. JPMorgan Chase & Co. lifted their price target on Schroders from GBX 386 to GBX 395 and gave the stock a “neutral” rating in a research report on Monday, October 20th. Deutsche Bank Aktiengesellschaft boosted their price objective on Schroders from GBX 400 to GBX 420 and gave the company a “hold” rating in a research note on Monday, October 6th. Royal Bank Of Canada raised their target price on shares of Schroders from GBX 435 to GBX 440 and gave the stock a “buy” rating in a research report on Thursday, October 30th. Finally, Citigroup cut their target price on shares of Schroders from GBX 435 to GBX 430 and set a “buy” rating on the stock in a report on Friday, October 24th.
Get Our Latest Research Report on Schroders
Schroders Price Performance
Schroders Company Profile
Schroders plc is a publicly owned investment manager. The firm also provides advisory and consultancy services. It provides its services to financial institutions, high net worth clients, large corporate, local authority, charitable entities, individuals, pension plans, government funds, insurance companies, and endowments. The firm launches and manages equity mutual funds and manages fixed income mutual funds for its clients. It also manages hedge for its clients. The firm invests in the public equity, fixed income, and alternative investment markets across the globe.
See Also
- Five stocks we like better than Schroders
- You Still Think Silver’s a Joke? Watch What Happens Next.
- A U.S. “birthright” claim worth trillions – activated quietly
- A month before the crash
- Elon Taking SpaceX Public! $100 Pre-IPO Opportunity!
- YDES Could Be 2026’s Biotech Breakthrough
Receive News & Ratings for Schroders Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Schroders and related companies with MarketBeat.com's FREE daily email newsletter.
